Primrose Bio Launches Two RNA Polymerases for High-Quality, Low-Cost mRNA
Up to 3x higher protein expression, >100x lower dsRNA, and major capping improvements Primrose to present at AMM Ascent and the International mRNA Health Conference SAN DIEGO, Oct. 14, 2026/PRNewswire/ -- Primrose Bio, Inc. ("Primrose"), a provider of production solutions for...
Covered in this story
What has happened since
- Ascent Industries is up 2.2% since this was published, 8 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $RNA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Atrium Therapeutics Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.